HK1008812A1 - Use of il-10 to prevent insulin-dependent diabetes mellitus - Google Patents

Use of il-10 to prevent insulin-dependent diabetes mellitus

Info

Publication number
HK1008812A1
HK1008812A1 HK98109511A HK98109511A HK1008812A1 HK 1008812 A1 HK1008812 A1 HK 1008812A1 HK 98109511 A HK98109511 A HK 98109511A HK 98109511 A HK98109511 A HK 98109511A HK 1008812 A1 HK1008812 A1 HK 1008812A1
Authority
HK
Hong Kong
Prior art keywords
diabetes mellitus
dependent diabetes
prevent insulin
insulin
prevent
Prior art date
Application number
HK98109511A
Other languages
English (en)
Inventor
Martha W Bond
Kevin W Moore
Kenneth Pennline
Paul J M Vieira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK1008812A1 publication Critical patent/HK1008812A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK98109511A 1992-10-01 1998-07-29 Use of il-10 to prevent insulin-dependent diabetes mellitus HK1008812A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95552392A 1992-10-01 1992-10-01
PCT/US1993/009030 WO1994008606A1 (en) 1992-10-01 1993-09-28 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus

Publications (1)

Publication Number Publication Date
HK1008812A1 true HK1008812A1 (en) 1999-05-21

Family

ID=25496932

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98109511A HK1008812A1 (en) 1992-10-01 1998-07-29 Use of il-10 to prevent insulin-dependent diabetes mellitus

Country Status (24)

Country Link
EP (1) EP0662837B1 (zh)
JP (1) JP2739770B2 (zh)
KR (1) KR0166663B1 (zh)
CN (1) CN1093598A (zh)
AT (1) ATE180168T1 (zh)
AU (1) AU689448B2 (zh)
CA (1) CA2145863A1 (zh)
CZ (1) CZ286866B6 (zh)
DE (1) DE69325029T2 (zh)
DK (1) DK0662837T3 (zh)
ES (1) ES2131122T3 (zh)
FI (1) FI951511A0 (zh)
GR (1) GR3030269T3 (zh)
HK (1) HK1008812A1 (zh)
HU (1) HU217871B (zh)
IL (1) IL107153A (zh)
MX (1) MX9306043A (zh)
MY (1) MY111543A (zh)
NO (1) NO951240L (zh)
SG (1) SG48733A1 (zh)
SK (1) SK281806B6 (zh)
TW (1) TW336172B (zh)
WO (1) WO1994008606A1 (zh)
ZA (1) ZA937244B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT76101A (en) * 1994-04-08 1997-06-30 Brigham & Womens Hospital Treatment of autoimmune disease using oral tolerization and/or th2-enhancing cytokines
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
CA2205572A1 (en) * 1994-12-12 1996-06-20 Beth Israel Hospital Association Chimeric cytokines and uses thereof
CA2228620A1 (en) * 1995-08-07 1997-02-20 John E. Oakes Treatment of ocular inflammatory conditions with interleukin-10
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
EP0845994A1 (en) * 1995-08-09 1998-06-10 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US5939069A (en) 1996-08-23 1999-08-17 University Of Florida Materials and methods for detection and treatment of immune system dysfunctions
WO1999006059A2 (en) * 1997-07-30 1999-02-11 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
US6171856B1 (en) 1997-07-30 2001-01-09 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
US6455528B1 (en) * 1997-10-14 2002-09-24 Mitsubishi Pharma Corporation Piperazine compounds and medicinal use thereof
JP2002289768A (ja) 2000-07-17 2002-10-04 Rohm Co Ltd 半導体装置およびその製法
CN100515491C (zh) * 2005-01-04 2009-07-22 健能隆医药技术（上海）有限公司 白介素-22的医药用途
JP6403062B2 (ja) * 2012-12-21 2018-10-10 国立大学法人徳島大学 組織修復活性組成物及びその利用
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
EP3442562B1 (en) 2016-04-15 2022-09-21 Evive Biotechnology (Shanghai) Ltd An il-22 dimer for use in treating necrotizing enterocolitis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
JPH07507567A (ja) 1995-08-24
IL107153A0 (en) 1993-12-28
CA2145863A1 (en) 1994-04-28
NO951240L (no) 1995-05-30
CN1093598A (zh) 1994-10-19
KR950703353A (ko) 1995-09-20
EP0662837A1 (en) 1995-07-19
KR0166663B1 (en) 1999-01-15
FI951511A (fi) 1995-03-30
SG48733A1 (en) 1998-05-18
HU217871B (hu) 2000-04-28
IL107153A (en) 2000-07-16
EP0662837B1 (en) 1999-05-19
FI951511A0 (fi) 1995-03-30
ZA937244B (en) 1994-06-27
MY111543A (en) 2000-08-30
WO1994008606A1 (en) 1994-04-28
AU5163593A (en) 1994-05-09
ES2131122T3 (es) 1999-07-16
CZ80495A3 (en) 1996-01-17
CZ286866B6 (en) 2000-07-12
AU689448B2 (en) 1998-04-02
NO951240D0 (no) 1995-03-30
MX9306043A (es) 1994-04-29
ATE180168T1 (de) 1999-06-15
GR3030269T3 (en) 1999-08-31
HU9500933D0 (en) 1995-05-29
DE69325029D1 (de) 1999-06-24
SK281806B6 (sk) 2001-08-06
TW336172B (en) 1998-07-11
DK0662837T3 (da) 1999-11-08
SK42395A3 (en) 1997-01-08
HUT71421A (en) 1995-11-28
JP2739770B2 (ja) 1998-04-15
DE69325029T2 (de) 1999-10-07

Similar Documents

Publication Publication Date Title
KR0166663B1 (en) Use of il-10 to prevent insulin-dependent diabetes mellitus
AU8163394A (en) Treatment of diabetes by administration of myo-inositol
EP0686203A4 (en) COMPOUNDS AND METHODS RELATING TO THE DIAGNOSIS, TREATMENT AND PREVENTION OF CELL DEATH DISEASES
AU7545594A (en) Implantable device for the treatment of aedemas
PL274899A1 (en) Agent for fighting against or preventing aggression by harmful insects or microorganisms
AU8138687A (en) Agents for combating pests and plant treatment agents
AU4714393A (en) Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity
EP0605024A3 (en) Use of purified surface modifiers to avoid aggregation of particles during sterilization.
PL272950A1 (en) Agent for combating or preventing attack by insects or microorganisms
AU6425496A (en) Treatment for juvenile diabetes
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
AU4376396A (en) Use of andrographolide compounds to treat or prevent pathogenicity of diseases
AU3730093A (en) Methods of treating diabetes
AU572285B2 (en) Polycyclic naphthacenecarboxamide antifouling treatment
AU8927191A (en) Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen
IL105285A0 (en) Compositions for the treatment of diabetes
ZA931063B (en) Treatment of glaucoma.
ZA913920B (en) Therapeutic compound
ZA931062B (en) Compositions for the treatment of glaucoma.
ES8500951A1 (es) Un procedimiento para preparar 6-metil-tio-espiro-ckroman-4,4' imidazolin-2',5'-diona.
JPS549258A (en) Epidesmosterol derivatives
GB9005050D0 (en) Treatment of diabetes
ZA919658B (en) New use of organic compounds.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)